vs
太平洋生物科学（ASMB）与ISABELLA BANK CORP（ISBA）财务数据对比。点击上方公司名可切换其他公司
ISABELLA BANK CORP的季度营收约是太平洋生物科学的2.0倍（$21.2M vs $10.8M），ISABELLA BANK CORP净利率更高（22.2% vs -85.2%，领先107.4%），太平洋生物科学同比增速更快（57.6% vs 14.3%），ISABELLA BANK CORP自由现金流更多（$23.3M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
菲律宾群岛银行是菲律宾的全能型银行，同时也是菲律宾乃至整个东南亚历史最悠久的银行。按资产规模计算，它是菲律宾第四大银行；按市值计算则位列第二，是菲律宾盈利能力最强的银行之一。
ASMB vs ISBA — 直观对比
营收规模更大
ISBA
是对方的2.0倍
$10.8M
营收增速更快
ASMB
高出43.3%
14.3%
净利率更高
ISBA
高出107.4%
-85.2%
自由现金流更多
ISBA
多$38.5M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $21.2M |
| 净利润 | $-9.2M | $4.7M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 32.2% |
| 净利率 | -85.2% | 22.2% |
| 营收同比 | 57.6% | 14.3% |
| 净利润同比 | 4.3% | 17.4% |
| 每股收益（稀释后） | $-0.72 | $0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBISBA
| Q4 25 | — | $21.2M | ||
| Q3 25 | $10.8M | $20.5M | ||
| Q2 25 | $9.6M | $18.8M | ||
| Q1 25 | $9.4M | $18.1M | ||
| Q4 24 | $7.4M | $18.5M | ||
| Q3 24 | $6.8M | $18.0M | ||
| Q2 24 | $8.5M | $17.2M | ||
| Q1 24 | $5.8M | $16.7M |
净利润ASMBISBA
| Q4 25 | — | $4.7M | ||
| Q3 25 | $-9.2M | $5.2M | ||
| Q2 25 | $-10.2M | $5.0M | ||
| Q1 25 | $-8.8M | $3.9M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-9.6M | $3.3M | ||
| Q2 24 | $-11.2M | $3.5M | ||
| Q1 24 | $-9.1M | $3.1M |
营业利润率ASMBISBA
| Q4 25 | — | 32.2% | ||
| Q3 25 | -100.9% | 30.7% | ||
| Q2 25 | -115.2% | 32.8% | ||
| Q1 25 | -105.5% | 26.9% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | -160.1% | 21.3% | ||
| Q2 24 | -143.0% | 23.9% | ||
| Q1 24 | -185.5% | 21.8% |
净利率ASMBISBA
| Q4 25 | — | 22.2% | ||
| Q3 25 | -85.2% | 25.6% | ||
| Q2 25 | -105.9% | 26.7% | ||
| Q1 25 | -93.6% | 21.9% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | -140.4% | 18.2% | ||
| Q2 24 | -130.7% | 20.3% | ||
| Q1 24 | -156.9% | 18.7% |
每股收益（稀释后）ASMBISBA
| Q4 25 | — | $0.64 | ||
| Q3 25 | $-0.72 | $0.71 | ||
| Q2 25 | $-1.33 | $0.68 | ||
| Q1 25 | $-1.17 | $0.53 | ||
| Q4 24 | — | $0.54 | ||
| Q3 24 | $-1.51 | $0.44 | ||
| Q2 24 | $-1.98 | $0.46 | ||
| Q1 24 | $-1.66 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $26.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $231.4M |
| 总资产 | $240.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBISBA
| Q4 25 | — | $26.0M | ||
| Q3 25 | $22.5M | $161.3M | ||
| Q2 25 | $24.0M | $108.6M | ||
| Q1 25 | $23.4M | $69.2M | ||
| Q4 24 | $38.3M | $24.5M | ||
| Q3 24 | $28.5M | $27.4M | ||
| Q2 24 | $19.2M | $23.6M | ||
| Q1 24 | $18.7M | $25.2M |
股东权益ASMBISBA
| Q4 25 | — | $231.4M | ||
| Q3 25 | $182.7M | $227.4M | ||
| Q2 25 | $18.1M | $220.5M | ||
| Q1 25 | $27.1M | $215.6M | ||
| Q4 24 | $33.4M | $210.3M | ||
| Q3 24 | $26.0M | $213.0M | ||
| Q2 24 | $34.7M | $202.2M | ||
| Q1 24 | $32.6M | $200.7M |
总资产ASMBISBA
| Q4 25 | — | $2.2B | ||
| Q3 25 | $240.0M | $2.3B | ||
| Q2 25 | $80.8M | $2.2B | ||
| Q1 25 | $99.0M | $2.1B | ||
| Q4 24 | $119.2M | $2.1B | ||
| Q3 24 | $100.3M | $2.1B | ||
| Q2 24 | $115.3M | $2.1B | ||
| Q1 24 | $119.9M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $26.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $23.3M |
| 自由现金流率自由现金流/营收 | -140.7% | 110.2% |
| 资本支出强度资本支出/营收 | 0.4% | 16.4% |
| 现金转化率经营现金流/净利润 | — | 5.72× |
| 过去12个月自由现金流最近4个季度 | — | $36.0M |
8季度趋势，按日历期对齐
经营现金流ASMBISBA
| Q4 25 | — | $26.8M | ||
| Q3 25 | $-15.1M | $2.7M | ||
| Q2 25 | $-16.8M | $7.8M | ||
| Q1 25 | $-23.4M | $4.7M | ||
| Q4 24 | $-51.1M | $19.6M | ||
| Q3 24 | $-15.2M | $3.6M | ||
| Q2 24 | $-17.1M | $5.5M | ||
| Q1 24 | $-18.4M | $3.4M |
自由现金流ASMBISBA
| Q4 25 | — | $23.3M | ||
| Q3 25 | $-15.2M | $1.7M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | $-51.1M | $17.5M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | $-17.1M | $5.1M | ||
| Q1 24 | $-18.4M | $2.6M |
自由现金流率ASMBISBA
| Q4 25 | — | 110.2% | ||
| Q3 25 | -140.7% | 8.5% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | -695.2% | 94.6% | ||
| Q3 24 | — | 17.7% | ||
| Q2 24 | -200.6% | 29.8% | ||
| Q1 24 | -317.7% | 15.7% |
资本支出强度ASMBISBA
| Q4 25 | — | 16.4% | ||
| Q3 25 | 0.4% | 5.0% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.0% | 5.5% | ||
| Q4 24 | 0.4% | 11.4% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.2% | 2.4% | ||
| Q1 24 | 0.2% | 4.9% |
现金转化率ASMBISBA
| Q4 25 | — | 5.72× | ||
| Q3 25 | — | 0.52× | ||
| Q2 25 | — | 1.56× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 4.91× | ||
| Q3 24 | — | 1.08× | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
